| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Opus Genetics, Inc. (IRD) has 10 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. IRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.49M | $27.41M | - | |
| ? | 1.99M | $9.94M | - | |
| CEO | 1.29M | $6.45M | - | |
| Pres | 319.0K | $1.59M | - | |
| ? | 297.3K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | Manuso James S J | Director | Buy | 4,434 | $0.00 | - | +43.7% | |
| Nov 19, 2020 | Ainsworth Sean | Director | Buy | 8,865 | $0.00 | - | +24.8% | |
| Jan 31, 2019 | Beever Charles | Director | Buy | 10,000 | $0.64 | $6,380.00 | +1,000% | |
| Jan 30, 2019 | Nolan Lisa | Chief Business Officer | Buy | 20,000 | $0.65 | $12,960.00 | +1,231% | |
| Jan 29, 2019 | Swirsky Douglas J | President And CEO | Buy | 50,000 | $0.63 | $31,720.00 | New | |
| Jan 29, 2019 | Price Ben Gil | Director | Buy | 15,000 | $0.61 | $9,141.00 | New | |
| Apr 10, 2017 | Ahn Chang Ho | Director | Sale+OE | 250,000 | $0.70 | $175,375.00 | -4.0% | |
| Jan 12, 2015 | Ahn Chang Ho | Director | Sale+OE | 314,656 | $0.91 | $286,772.37 | -1.7% | |
| Jan 12, 2015 | Jeong Tae Heum | Chief Financial Officer | Sale+OE | 317,272 | $0.91 | $289,135.57 | -17.3% |